Chinese Journal of Cancer Research
搜索
Chinese Journal of Cancer Research
2022年6期
浏览往期
订阅
目录
Review Article
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics
Burden of liver cancer: From epidemiology to prevention
Perspective
Postoperative functional evaluation of gastrectomy for gastric cancer
Advances in gastric cancer research will light the way to control this cancer
Evolution of laparoscopic gastrectomy for cancer in the East and West
Advances in surgical techniques for gastric cancer: Indocyanine green and near-infrared fluorescence imaging.Is it ready for prime time?
Original Article
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic,multicenter,and prospective clinical trial in China
A multi-center,open-label,randomized,parallel-controlled phase II study comparing pharmacokinetic,pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera®) in patients with CD20-positive B-cell non-Hodgkin lymphoma
Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1expression in remnant gastric cancer
Clinical Practice
Chinese quality control indices for standardized diagnosis and treatment of gastric cancer (2022 edition)
Editorial
Comments on National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
Corrigendum
Corrigendum to Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)